Outsourced Sequencing, Field Programmable Gate Arrays, Tissue Arrays, and Proteomics in the Clinic | GenomeWeb

The March 2004 cover story of Genome Technology focused on a new trend in DNA sequencing: outsourcing. To get the throughput needed for their projects, some researchers began to turn to companies rather than to their institutions' core labs. Since then, next-generation sequencing has exploded onto the scene, bringing even higher throughput with it — and outsourcing is still going strong. At the time of the article, Lark Technologies had just been acquired by Genaissance which was, in turn, bought by Clinical Data in June 2005.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions.

Ancestry.com is eyeing an expansion into genomic risk assessments, the Verge reports.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Sponsored by

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit. 

Sponsored by

This webinar will focus on a range of research and clinical applications enabled by improvements in mate pair technology for whole genome sequencing.